A detailed history of Park Edge Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Park Edge Advisors, LLC holds 4,685 shares of ABT stock, worth $530,763. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,685
Previous 4,685 -0.0%
Holding current value
$530,763
Previous $486,000 9.88%
% of portfolio
0.17%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$109.52 - $120.96 $16,428 - $18,144
-150 Reduced 3.1%
4,685 $532,000
Q4 2023

Jan 12, 2024

SELL
$90.19 - $110.4 $20,112 - $24,619
-223 Reduced 4.41%
4,835 $532,000
Q1 2023

Apr 18, 2023

BUY
$96.86 - $114.01 $43,587 - $51,304
450 Added 9.77%
5,058 $512 Million
Q4 2022

Apr 14, 2023

BUY
$95.06 - $111.52 $438,036 - $513,884
4,608 New
4,608 $506 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Park Edge Advisors, LLC Portfolio

Follow Park Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Edge Advisors, LLC with notifications on news.